Cantor Fitzgerald Starts Bruker (BRKR) at Buy
Get Alerts BRKR Hot Sheet
Price: $59.02 +5.34%
Rating Summary:
15 Buy, 11 Hold, 2 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 7 | Down: 11 | New: 32
Rating Summary:
15 Buy, 11 Hold, 2 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 7 | Down: 11 | New: 32
Join SI Premium – FREE
After the close, Cantor Fitzgerald initiated coverage on Bruker (NASDAQ: BRKR) with a Buy. PT $16.00.
The firm comments, "In our view, the company is well positioned to capitalize on high-growth market segments over the next several years and deliver above-market top line growth, leveraging internal R&D and strategic tuck-ins. Additionally, with below sector average margins, Bruker has significant upside for margin expansion in the medium-term." Cantor also sees high barriers to entry as the company develops high-end scientific instrumentation.
For an analyst ratings summary and ratings history on Bruker click here. For more ratings news on Bruker click here.
Shares of Bruker closed at $13.39 yesterday.
The firm comments, "In our view, the company is well positioned to capitalize on high-growth market segments over the next several years and deliver above-market top line growth, leveraging internal R&D and strategic tuck-ins. Additionally, with below sector average margins, Bruker has significant upside for margin expansion in the medium-term." Cantor also sees high barriers to entry as the company develops high-end scientific instrumentation.
For an analyst ratings summary and ratings history on Bruker click here. For more ratings news on Bruker click here.
Shares of Bruker closed at $13.39 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cantor Fitzgerald Starts Tempus AI Inc (TEM) at Overweight
- Canaccord Starts BillionToOne Inc (BLLN) at Buy
- Scotiabank Starts Webull (BULL) at Sector Outperform
Create E-mail Alert Related Categories
New CoverageRelated Entities
Cantor FitzgeraldSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share